• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Surgical Outcomes and Associated Morbidity of Active and Expectant Management of Second-Trimester Placenta Accreta Spectrum (PAS).孕中期胎盘植入谱系疾病(PAS)积极处理与期待治疗的手术结局及相关并发症
Medicina (Kaunas). 2025 Jan 14;61(1):113. doi: 10.3390/medicina61010113.
2
[Outcome analysis of pregnancy termination and expectant treatment in pregnant women with suspected invasive placenta accreta spectrum disorders in the second trimester].[孕中期疑似胎盘植入谱系疾病孕妇终止妊娠与期待治疗的结局分析]
Zhonghua Fu Chan Ke Za Zhi. 2023 Jul 25;58(7):489-494. doi: 10.3760/cma.j.cn112141-20230130-00030.
3
Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS).与全麻相比,在胎盘植入谱系(PAS)行剖宫产子宫切除术时,转为脊麻-全麻联合麻醉在术中及术后转归方面具有同等优势。
J Matern Fetal Neonatal Med. 2022 Dec;35(25):8640-8644. doi: 10.1080/14767058.2021.1990885. Epub 2021 Oct 17.
4
Uterine conservation in placenta accrete spectrum (PAS) disorders: A retrospective case series: Is expectant management beneficial in reducing maternal morbidity?胎盘植入谱系疾病(PAS)中保留子宫:一项回顾性病例系列研究:期待治疗对降低孕产妇发病率有益吗?
Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:212-217. doi: 10.1016/j.ejogrb.2020.09.029. Epub 2020 Sep 24.
5
Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).妇科肿瘤学家在胎盘植入谱系疾病(PAS)剖宫产子宫切除术中的管理作用
Gynecol Oncol. 2022 Sep;166(3):460-464. doi: 10.1016/j.ygyno.2022.06.025. Epub 2022 Jul 1.
6
Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.女性行剖宫产术治疗胎盘植入谱系疾病的泌尿系统并发症:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2023 Nov;62(5):633-643. doi: 10.1002/uog.26299.
7
[Risk factor assessment and adverse outcome prediction of placenta accreta in pregnant women after cesarean section complicated with placenta previa: a national multicenter retrospective study].剖宫产术后合并前置胎盘孕妇胎盘植入的危险因素评估及不良结局预测:一项全国多中心回顾性研究
Zhonghua Fu Chan Ke Za Zhi. 2023 Jan 25;58(1):26-36. doi: 10.3760/cma.j.cn112141-20221009-00615.
8
Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.术中多血管栓塞治疗胎盘植入谱系疾病:PASTIME方案
Am J Obstet Gynecol. 2021 Oct;225(4):442.e1-442.e10. doi: 10.1016/j.ajog.2021.07.001. Epub 2021 Jul 7.
9
Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies.胎盘植入谱系疾病(PAS)病理对剖宫产子宫切除术中新生儿呼吸结局的影响。
J Matern Fetal Neonatal Med. 2022 Dec;35(26):10692-10697. doi: 10.1080/14767058.2022.2157716. Epub 2022 Dec 15.
10
Risk of Subsequent Hysterectomy after Expectant Management in the Treatment of Placenta Accreta Spectrum Disorders.期待治疗在胎盘植入谱系疾病治疗中后继发子宫切除术的风险。
Medicina (Kaunas). 2022 May 19;58(5):678. doi: 10.3390/medicina58050678.

引用本文的文献

1
Rectangular-Shaped Hemostatic Sutures in the Management of Second-Trimester Placenta Accreta Spectrum Disorders at Tu Du Hospital, Vietnam: A Retrospective Descriptive Study.越南图度医院采用矩形止血缝合术治疗孕中期胎盘植入谱系疾病:一项回顾性描述性研究
AJP Rep. 2025 Jun 10;15(2):e79-e88. doi: 10.1055/a-2608-0990. eCollection 2025 Apr.

本文引用的文献

1
Placenta accreta spectrum in the second trimester: a clinical conundrum in procedural abortion care.孕中期胎盘植入谱系疾病:人工流产护理中的临床难题
Am J Obstet Gynecol. 2025 Jan;232(1):92-101. doi: 10.1016/j.ajog.2024.07.045. Epub 2024 Aug 6.
2
One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial.一步法保守性手术与子宫切除术治疗胎盘植入谱系疾病的比较:一项可行性随机对照试验。
Am J Obstet Gynecol MFM. 2024 Jun;6(6):101333. doi: 10.1016/j.ajogmf.2024.101333. Epub 2024 Mar 6.
3
Placenta accreta spectrum care infrastructure: an evidence-based review of needed resources supporting placenta accreta spectrum care.胎盘植入谱系疾病照护基础设施:支持胎盘植入谱系疾病照护所需资源的循证评价。
Am J Obstet Gynecol MFM. 2024 Jan;6(1):101229. doi: 10.1016/j.ajogmf.2023.101229. Epub 2023 Nov 18.
4
Prophylactic ureteral stent placement for the prevention of genitourinary tract injury during hysterectomy for placenta accreta spectrum: systematic review and meta-analysis.
Am J Obstet Gynecol MFM. 2023 Oct;5(10):101120. doi: 10.1016/j.ajogmf.2023.101120. Epub 2023 Aug 5.
5
Imaging the Uterus in Placenta Accreta Spectrum Disorder.胎盘植入谱系疾病的子宫影像学。
Am J Perinatol. 2023 Jul;40(9):1013-1025. doi: 10.1055/s-0043-1761914. Epub 2023 Jun 19.
6
Factors Limiting Magnetic Resonance Imaging Diagnosis of Placenta Accreta Spectrum.胎盘植入谱系疾病磁共振成像诊断的限制因素。
Am J Perinatol. 2023 Oct;40(13):1398-1405. doi: 10.1055/a-2099-4542. Epub 2023 May 24.
7
Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum.胎盘植入谱系疾病子宫动脉栓塞术和氨甲环酸方案的实施和结果。
Am J Obstet Gynecol. 2023 Jul;229(1):61.e1-61.e7. doi: 10.1016/j.ajog.2023.03.028. Epub 2023 Mar 23.
8
Timing of delivery for placenta accreta spectrum: the Pan-American Society for the Placenta Accreta Spectrum experience.胎盘植入谱系疾病的分娩时机:泛美胎盘植入谱系疾病协会的经验
Am J Obstet Gynecol MFM. 2022 Nov;4(6):100718. doi: 10.1016/j.ajogmf.2022.100718. Epub 2022 Aug 14.
9
Outcomes in emergency versus electively scheduled cases of placenta accreta spectrum disorder managed by cesarean-hysterectomy within a multidisciplinary care team.在多学科护理团队中,剖宫产子宫切除术治疗的胎盘植入谱系障碍急诊病例与择期病例的结局。
Int J Gynaecol Obstet. 2022 Nov;159(2):404-411. doi: 10.1002/ijgo.14121. Epub 2022 Feb 15.
10
Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study.51 例前置胎盘和胎盘植入谱系疾病患者剖宫产术后中期妊娠终止的临床分析:一项回顾性研究。
BMC Pregnancy Childbirth. 2021 Aug 18;21(1):568. doi: 10.1186/s12884-021-04017-8.

孕中期胎盘植入谱系疾病(PAS)积极处理与期待治疗的手术结局及相关并发症

Surgical Outcomes and Associated Morbidity of Active and Expectant Management of Second-Trimester Placenta Accreta Spectrum (PAS).

作者信息

Munoz Jessian L, Counts Rachel, Lacue Amanda E, Ireland Kayla E, Ramsey Patrick S, Brandi Kristyn

机构信息

Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Division of Fetal Intervention, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.

Department of Obstetrics & Gynecology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX 78229, USA.

出版信息

Medicina (Kaunas). 2025 Jan 14;61(1):113. doi: 10.3390/medicina61010113.

DOI:10.3390/medicina61010113
PMID:39859095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11766860/
Abstract

Management of second-trimester placenta accreta spectrum (PAS) is currently center-dependent with minimal evidence-based practices. This study aims to analyze outcomes of hysterectomy as second-trimester active management (AM) versus cesarean hysterectomy as expectant management (EM) in cases of PAS with intraoperative and postoperative outcomes. This study is a retrospective case-control study of patients with a pathology-confirmed diagnosis of PAS managed at a single center over 16 years (2005-2020). All cases were diagnosed during the first or second trimester by ultrasonography and managed by the same multidisciplinary team with delivery within the second trimester. : Thirty-four patients with PAS were diagnosed and delivered by the second trimester. Of these, (41.1%) elected for active management and 20 (58.9%) for expectant management but ultimately required delivery prior to 28 weeks' gestation. Baseline demographics were similar between groups. Intraoperatively, no differences were noted in operative time (191.5 vs. 203 min, = 0.85), blood loss (2300 vs. 2600 cc, = 0.85), or incidental cystotomy (1 vs. 7, = 0.10). Postoperative length of stay was similar (3 vs. 3.5 days, = 0.28), and ICU admission was not statistically different (6 vs. 12, = 0.48). : This retrospective study suggests that when hysterectomy is planned, there is no difference in maternal outcomes and morbidity with an expectant management with cesarean hysterectomy in the second trimester compared to proactive cesarean hysterectomy.

摘要

孕中期胎盘植入谱系疾病(PAS)的管理目前依赖于各个中心,基于循证实践的做法很少。本研究旨在分析在PAS病例中,子宫切除术作为孕中期积极管理(AM)与剖宫产子宫切除术作为期待管理(EM)的术中及术后结果。本研究是一项回顾性病例对照研究,研究对象为在16年(2005 - 2020年)期间于单一中心接受病理确诊为PAS的患者。所有病例均在孕早期或孕中期通过超声诊断,并由同一多学科团队管理,在孕中期分娩。34例PAS患者在孕中期被诊断并分娩。其中,14例(41.1%)选择积极管理,20例(58.9%)选择期待管理,但最终均在妊娠28周前分娩。两组间基线人口统计学特征相似。术中,手术时间(191.5 vs. 203分钟,P = 0.85)、失血量(2300 vs. 2600毫升,P = 0.85)或意外膀胱切开术(1 vs. 7,P = 0.10)均无差异。术后住院时间相似(3 vs. 3.5天,P = 0.28),重症监护病房(ICU)入住率在统计学上无差异(6 vs. 12,P = 0.48)。这项回顾性研究表明,当计划进行子宫切除术时,与孕中期积极的剖宫产子宫切除术相比,期待管理下的剖宫产子宫切除术在孕产妇结局和发病率方面并无差异。